You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
5 October 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) said on Monday that it has completed a USD2bn strategic equity investment in biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) to support...
5 October 2026 - Medical technology company GE HealthCare (Nasdaq:GEHC) announced on Monday that it has agreed to acquire SOFIE Biosciences from Trilantic North America for USD945m in cash, expanding its US radiopharmaceutical manufacturing footprint...
5 October 2026 - Australian biopharma company CSL Limited (ASX:CSL) (USOTC:CSLLY) and Swiss biotechnology company Alentis Therapeutics announced on Sunday that they have entered into an exclusive global collaboration agreement to co-develop and co-pr...
5 October 2026 - Aroa Biosurgery Limited (ASX:ARX), a New Zealand-based soft tissue regeneration company, on Monday reported positive results from a prospective, multicentre randomised controlled trial (RCT) of Symphony, published in the Internationa...
Johnson & Johnson reports two-year ICOTYDE data showing sustained clearance in high-impact psoriasis
2 October 2026 - US healthcare company Johnson & Johnson (NYSE: JNJ) on Friday announced the release of two-year Phase 3 results from ICONIC-TOTAL assessing ICOTYDE (icotrokinra) in adults and adolescents with moderate high-impact plaque psoriasi...
2 October 2026 - Avimer Bio, a California-based biotechnology company, in collaboration with structural biologists at the Spanish National Cancer Research Centre (CNIO), announced on Thursday a new publication in the Journal of the American Chemical ...
2 October 2026 - Cerapedics Inc., a US-based, commercial-stage musculoskeletal company involved in bone repair, announced on Thursday that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status ...